{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:13:29Z","timestamp":1789787609734,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004908"],"award-info":[{"award-number":["I01 BX004908"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA269995"],"award-info":[{"award-number":["R01 CA269995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R37 CA212617"],"award-info":[{"award-number":["R37 CA212617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 NS107813"],"award-info":[{"award-number":["R01 NS107813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.addr.2026.115811","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:15:20Z","timestamp":1771028120000},"page":"115811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment"],"prefix":"10.1016","volume":"232","author":[{"given":"Ananya H.","family":"Elati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika W.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Winkles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme F.","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115811_bb0005","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/brainsci13111536","article-title":"Advances in glioblastoma therapy: an update on current approaches","volume":"13","author":"Angom","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.addr.2026.115811_bb0010","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.addr.2026.115811_bb0015","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.addr.2026.115811_bb0020","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","article-title":"Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study","volume":"27","author":"Mohammed","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.addr.2026.115811_bb0025","series-title":"Glioblastoma","article-title":"Current standards of Care in Glioblastoma Therapy","author":"Fernandes","year":"2017"},{"key":"10.1016\/j.addr.2026.115811_bb0030","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/cancers12092511","article-title":"Radioresistance in glioblastoma and the development of Radiosensitizers","volume":"12","author":"Ali","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.addr.2026.115811_bb0035","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"CDR"},{"key":"10.1016\/j.addr.2026.115811_bb0040","article-title":"The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update","volume":"150","author":"Z. M","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0045","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115811_bb0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma Multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"JCO"},{"key":"10.1016\/j.addr.2026.115811_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2019.07.017","article-title":"Radiosensitization of high-grade gliomas through induced hyperthermia: review of clinical experience and the potential role of MR-guided focused ultrasound","volume":"142","author":"Schneider","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijrobp.2021.05.001","article-title":"Dose escalated radiation therapy for glioblastoma Multiforme: an international systematic review and Meta-analysis of 22 prospective trials","volume":"111","author":"Singh","year":"2021","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.addr.2026.115811_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol","volume":"60","author":"Souhami","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.addr.2026.115811_bb0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1538-7445.AM2024-696","article-title":"Abstract 696: proton radiation and Seco-Duocarmycin SA: a synergistic strategy unveiling new frontiers in glioblastoma multiforme therapy","volume":"84","author":"Morcos","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2026.115811_bb0075","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/noajnl\/vdab024.080","article-title":"FSMP-17. Global metabolomic profiling of glioblastoma multiforme reveals metabolic vulnerabilities in response to radiation therapy","volume":"3","author":"Durairaj","year":"2021","journal-title":"Neuro-Oncology Advances"},{"key":"10.1016\/j.addr.2026.115811_bb0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11060-020-03459-y","article-title":"Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice","volume":"147","author":"Stessin","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0085","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO-25-00618","article-title":"Dual immune check point blockade in MGMT-unmethylated newly diagnosed glioblastoma: NRG oncology BN007, a randomized phase II\/III clinical trial","volume":"43","author":"Lassman","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0090","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1535-7163.MCT-24-0003","article-title":"DNA-PK inhibition shows differential radiosensitization in orthotopic GBM PDX models based on DDR pathway deficits","volume":"24","author":"Dragojevic","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2026.115811_bb0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115811_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1208876","article-title":"Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma","volume":"5","author":"Roberts","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.addr.2026.115811_bb0105","first-page":"471","article-title":"Understanding and improving platinum anticancer drugs--phenanthriplatin","volume":"34","author":"Johnstone","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.addr.2026.115811_bb0110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.oraloncology.2014.08.005","article-title":"Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies","volume":"50","author":"Petrelli","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0115","doi-asserted-by":"crossref","first-page":"1259331","DOI":"10.3389\/fonc.2023.1259331","article-title":"Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"13","author":"Zhu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0120","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/nano13101619","article-title":"Platinum-based Nanoformulations for glioblastoma treatment: the resurgence of platinum drugs?","volume":"13","author":"Alfonso-Triguero","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.addr.2026.115811_bb0125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S1415-475738420150019","article-title":"Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer","volume":"38","author":"Borrego-Soto","year":"2015","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.addr.2026.115811_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12951-020-00684-5","article-title":"Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme","volume":"18","author":"Choi","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41420-021-00554-5","article-title":"Platinum drugs and taxanes: can we overcome resistance?","volume":"7","author":"Sazonova","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.addr.2026.115811_bb0140","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1021\/acs.molpharmaceut.5b00531","article-title":"A novel platinum\u2013maurocalcine conjugate induces apoptosis of human glioblastoma cells by acting through the ROS-ERK\/AKT-p53 pathway","volume":"12","author":"Aroui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115811_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102754","article-title":"Drug-induced oxidative stress in cancer treatments: angel or devil?","volume":"63","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.addr.2026.115811_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dnarep.2014.03.014","article-title":"DNA double-strand break repair pathway choice and cancer","volume":"19","author":"Aparicio","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.addr.2026.115811_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","article-title":"Cisplatin sensitizes Cancer cells to ionizing radiation via inhibition of nonhomologous end joining","volume":"3","author":"Boeckman","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.addr.2026.115811_bb0160","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1039\/D1DT03700E","article-title":"Platinum complexes as inhibitors of DNA repair protein Ku70 and topoisomerase II\u03b1 in cancer cells","volume":"51","author":"Zhang","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.addr.2026.115811_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101656","article-title":"Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to boost antitumor immunity","volume":"47","author":"Deng","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2026.115811_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/inorganics12120331","article-title":"Platinum\u2013iron nanoparticles for oxygen-enhanced sonodynamic tumor cell suppression","volume":"12","author":"Dong","year":"2024","journal-title":"Inorganics"},{"key":"10.1016\/j.addr.2026.115811_bb0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2019.01.004","article-title":"Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivo","volume":"197","author":"Li","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115811_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122901","article-title":"Engineered bacterium-metal-organic framework biohybrids for boosting radiotherapy with multiple effects","volume":"314","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115811_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2024.255","article-title":"Role of HIF-1\u03b1 in the responses of tumors to radiotherapy and chemotherapy","volume":"57","author":"Song","year":"2025","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.addr.2026.115811_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12951-025-03132-4","article-title":"Overcoming hypoxia-induced breast cancer drug resistance: a novel strategy using hollow gold-platinum bimetallic nanoshells","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0195","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1021\/acsnano.5c00691","article-title":"Biotin receptor-targeting Pt<sup>IV<\/sup> oxygen carrying prodrug Amphiphile for alleviating tumor hypoxia induced immune chemotherapy suppression","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115811_bb0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","article-title":"Endoplasmic reticulum stress\u2014a key guardian in cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.addr.2026.115811_bb0205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.4291","article-title":"A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress","volume":"23","author":"Bruno","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2026.115811_bb0210","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1039\/D2DT02068H","article-title":"Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs","volume":"51","author":"Ghini","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.addr.2026.115811_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11060-018-2979-1","article-title":"Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction","volume":"140","author":"Roberts","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12645-023-00242-2","article-title":"Anticancer platinum-drug delivered by mesenchymal stromal cells improves its activity on glioblastoma","volume":"15","author":"Cocc\u00e8","year":"2024","journal-title":"Cancer Nano"},{"key":"10.1016\/j.addr.2026.115811_bb0225","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fbioe.2020.00748","article-title":"Recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of Cancer","volume":"8","author":"Babajani","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0230","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/1061186X.2024.2347356","article-title":"Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents","volume":"32","author":"Waqar","year":"2024","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2026.115811_bb0235","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1002\/ijc.31619","article-title":"The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy-induced toxicity","volume":"143","author":"R\u00fchle","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2026.115811_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13287-017-0516-3","article-title":"Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts","volume":"8","author":"Pacioni","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2026.115811_bb0245","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115811_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-009-0011-5","article-title":"Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation","volume":"97","author":"Charest","year":"2010","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0255","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10637-015-0228-4","article-title":"Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model","volume":"33","author":"Shi","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.addr.2026.115811_bb0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12951-018-0404-8","article-title":"Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats","volume":"16","author":"Shi","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10637-016-0340-0","article-title":"Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model","volume":"34","author":"Shi","year":"2016","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.addr.2026.115811_bb0270","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1200\/JCO.2023.41.16_suppl.3130","article-title":"Predictive biomarker for cisplatin in prospective phase 2 of liposomal cisplatin in metastatic breast cancer","volume":"41","author":"Nielsen","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.addr.2026.115811_bb0275","first-page":"541","article-title":"Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer","volume":"30","author":"Seetharamu","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.addr.2026.115811_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114415","article-title":"Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment","volume":"188","author":"Pandey","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115811_bb0285","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1039\/C4NR03693J","article-title":"Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma","volume":"6","author":"Setua","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2026.115811_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132266","article-title":"Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma","volume":"10","author":"Arshad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2026.115811_bb0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0300","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.3390\/cancers14194920","article-title":"Applications of focused ultrasound for the treatment of glioblastoma: a new frontier","volume":"14","author":"Hersh","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.addr.2026.115811_bb0305","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/thno.26869","article-title":"State-of-the-art of microbubble-assisted blood-brain barrier disruption","volume":"8","author":"Song","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115811_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114043","article-title":"Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound","volume":"180","author":"Schoen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115811_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12951-023-02074-z","article-title":"Focused ultrasound-mediated blood-brain barrier opening combined with magnetic targeting cytomembrane based biomimetic microbubbles for glioblastoma therapy","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115811_bb0320","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.nano.2018.01.021","article-title":"Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound","volume":"14","author":"Coluccia","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2026.115811_bb0325","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood\u2013brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115811_bb0330","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12967-024-05096-9","article-title":"Focused ultrasound-mediated blood\u2013brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma","volume":"22","author":"Tazhibi","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2026.115811_bb0335","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-023-04517-x","article-title":"Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study","volume":"165","author":"Chen","year":"2023","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2026.115811_bb0340","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ultrasmedbio.2023.01.014","article-title":"Ultrasound and microbubbles increase the uptake of platinum in murine Orthotopic pancreatic tumors","volume":"49","author":"Haram","year":"2023","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.addr.2026.115811_bb0345","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1158\/1535-7163.MCT-09-0201","article-title":"Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90","volume":"8","author":"Dungey","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2026.115811_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225619","article-title":"BMN673 is a PARP inhibitor with unique Radiosensitizing properties: mechanisms and potential in radiation therapy","volume":"14","author":"Soni","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.addr.2026.115811_bb0355","doi-asserted-by":"crossref","first-page":"eadd2288","DOI":"10.1126\/sciadv.add2288","article-title":"Spatially targeted brain cancer immunotherapy with closed-loop controlled focused ultrasound and immune checkpoint blockade","volume":"8","author":"Lee","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2026.115811_bb0360","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2026.115811_bb0365","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/1381612828666220607105746","article-title":"The mechanisms of current platinum anticancer drug resistance in the glioma","volume":"28","author":"Lu","year":"2022","journal-title":"CPD"},{"key":"10.1016\/j.addr.2026.115811_bb0370","doi-asserted-by":"crossref","first-page":"1506206","DOI":"10.3389\/fcell.2025.1506206","article-title":"Platinum(IV) anticancer therapies and cathepsin B: innovative strategies for overcoming resistance in glioblastoma cells","volume":"13","author":"Casali","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2026.115811_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13815","article-title":"span style=\u201cfont-variant:small-caps;\u201d>DNA<\/span> damage repair in glioblastoma: a novel approach to combat drug resistance","volume":"58","author":"Gaiaschi","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.addr.2026.115811_bb0380","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00280-018-3662-0","article-title":"A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity","volume":"82","author":"Chung","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2026.115811_bb0385","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/biomedicines12061230","article-title":"Microbubble-enhanced focused ultrasound for infiltrating gliomas","volume":"12","author":"Seas","year":"2024","journal-title":"Biomedicines"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:34:11Z","timestamp":1779006851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":77,"alternative-id":["S0169409X26000451"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115811","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platinum-based therapeutics as emerging multi-modal radiosensitizers in glioblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115811"}}